ATE353359T1 - Für die humane untereinheit 5-ht3-c des serotoninrezeptors 5-ht3 kodierende dna - Google Patents
Für die humane untereinheit 5-ht3-c des serotoninrezeptors 5-ht3 kodierende dnaInfo
- Publication number
- ATE353359T1 ATE353359T1 AT00959229T AT00959229T ATE353359T1 AT E353359 T1 ATE353359 T1 AT E353359T1 AT 00959229 T AT00959229 T AT 00959229T AT 00959229 T AT00959229 T AT 00959229T AT E353359 T1 ATE353359 T1 AT E353359T1
- Authority
- AT
- Austria
- Prior art keywords
- dna coding
- receptor
- human
- human subunit
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/286—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against neuromediator receptors, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/388,349 US6365370B1 (en) | 1999-09-01 | 1999-09-01 | DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE353359T1 true ATE353359T1 (de) | 2007-02-15 |
Family
ID=23533753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00959229T ATE353359T1 (de) | 1999-09-01 | 2000-08-14 | Für die humane untereinheit 5-ht3-c des serotoninrezeptors 5-ht3 kodierende dna |
Country Status (11)
Country | Link |
---|---|
US (3) | US6365370B1 (de) |
EP (1) | EP1218491B1 (de) |
JP (1) | JP2003508048A (de) |
AT (1) | ATE353359T1 (de) |
AU (1) | AU776347B2 (de) |
CA (1) | CA2384026A1 (de) |
DE (1) | DE60033297T2 (de) |
DK (1) | DK1218491T3 (de) |
ES (1) | ES2281355T3 (de) |
HK (1) | HK1047767B (de) |
WO (1) | WO2001016297A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001068849A2 (en) * | 2000-03-10 | 2001-09-20 | Pharmacia & Upjohn Company | Human ion channels |
WO2002002639A2 (en) * | 2000-07-05 | 2002-01-10 | Pharmacia & Upjohn Company | Human ion channels |
US20030024001A1 (en) * | 2001-07-27 | 2003-01-30 | Wyeth | Knock in transgenic mammal containing a non-functional N-terminus of Kv beta 1.1 subunit |
AUPR701101A0 (en) * | 2001-08-14 | 2001-09-06 | Commonwealth Scientific And Industrial Research Organisation | Agonists and antagonists of 5ht3-like receptors of invertebrates as pesticides |
GB0217920D0 (en) * | 2002-04-23 | 2002-09-11 | Aventis Pharm Prod Inc | Interleukin-4 Gene Expression inhibitors |
US20040096089A1 (en) * | 2002-08-16 | 2004-05-20 | David Borsook | Non-invasive functional imaging of peripheral nervous system activation in humans and animals |
WO2006021347A2 (en) * | 2004-08-26 | 2006-03-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine receptor 3c (5-ht3c) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6462188B1 (en) * | 1998-04-16 | 2002-10-08 | The Institute For Genomic Research | Human 5-HT3 receptor |
CA2374432A1 (en) * | 1999-05-24 | 2000-11-30 | Ortho-Mcneil Pharmaceutical, Inc. | Dna encoding a human subunit of the 5-ht3 serotonin receptor |
WO2002002639A2 (en) * | 2000-07-05 | 2002-01-10 | Pharmacia & Upjohn Company | Human ion channels |
-
1999
- 1999-09-01 US US09/388,349 patent/US6365370B1/en not_active Expired - Lifetime
-
2000
- 2000-08-14 DK DK00959229T patent/DK1218491T3/da active
- 2000-08-14 DE DE60033297T patent/DE60033297T2/de not_active Expired - Lifetime
- 2000-08-14 EP EP00959229A patent/EP1218491B1/de not_active Expired - Lifetime
- 2000-08-14 CA CA002384026A patent/CA2384026A1/en not_active Abandoned
- 2000-08-14 ES ES00959229T patent/ES2281355T3/es not_active Expired - Lifetime
- 2000-08-14 JP JP2001520845A patent/JP2003508048A/ja not_active Withdrawn
- 2000-08-14 AT AT00959229T patent/ATE353359T1/de not_active IP Right Cessation
- 2000-08-14 AU AU70583/00A patent/AU776347B2/en not_active Ceased
- 2000-08-14 WO PCT/US2000/022271 patent/WO2001016297A1/en active IP Right Grant
-
2001
- 2001-09-12 US US09/955,524 patent/US20020137138A1/en not_active Abandoned
-
2002
- 2002-12-24 HK HK02109335.3A patent/HK1047767B/zh not_active IP Right Cessation
-
2003
- 2003-09-12 US US10/661,378 patent/US7109296B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2001016297A1 (en) | 2001-03-08 |
EP1218491A1 (de) | 2002-07-03 |
AU7058300A (en) | 2001-03-26 |
EP1218491B1 (de) | 2007-02-07 |
ES2281355T3 (es) | 2007-10-01 |
HK1047767A1 (en) | 2003-03-07 |
CA2384026A1 (en) | 2001-03-08 |
US6365370B1 (en) | 2002-04-02 |
US7109296B2 (en) | 2006-09-19 |
DE60033297D1 (de) | 2007-03-22 |
JP2003508048A (ja) | 2003-03-04 |
DK1218491T3 (da) | 2007-04-23 |
EP1218491A4 (de) | 2003-05-28 |
HK1047767B (zh) | 2007-06-01 |
AU776347B2 (en) | 2004-09-02 |
US20050124795A1 (en) | 2005-06-09 |
DE60033297T2 (de) | 2007-10-25 |
US20020137138A1 (en) | 2002-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE310098T1 (de) | Dna kodierend für glutaminsäure-gesteuerte chloridkanäle | |
DE69637874D1 (de) | C-C CHEMOKIN REZEPTOR 3: CKR-3 ODER Eos-L2 | |
DE69635899D1 (de) | Polypeptid, das die differenzierung unterdrueckt | |
EP1392835A4 (de) | Epressionsvektor für tierische zellen | |
HUP0105337A2 (hu) | Az immunválaszban szerepet játszó új polipeptidek | |
ATE404583T1 (de) | Funktionelle antagonisten von hedgehog-aktivität | |
DE60120356D1 (de) | Verbesserte galactosylierung von rekombinanten proteinen | |
ATE353359T1 (de) | Für die humane untereinheit 5-ht3-c des serotoninrezeptors 5-ht3 kodierende dna | |
HUP0104022A2 (hu) | Béta-szekretáz típusú aktivitással rendelkező polipeptidek | |
ATE303439T1 (de) | Intrazelluläre isoform von interleukin-1 rezeptor antagonist | |
DE60039677D1 (de) | Akt-3 nukleinsäure, polypeptide und deren verwendung | |
WO2000063415A8 (en) | Dna encoding the human vanilloid receptor vr1 | |
MXPA02007751A (es) | Acido desoxirribonucleico que codifica receptor vaniloide vr3. | |
DE60235985D1 (de) | Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk) | |
DE69535590D1 (de) | Für den bradykinin-b1-rezeptor kodierende dna | |
ATE335826T1 (de) | Proteinherstellung | |
FI971896A0 (fi) | BMP-tyyppi II-reseptoria koodaava cDNA | |
TR200103448T2 (tr) | IL-8 reseptör antagonistleri. | |
MXPA02012223A (es) | La subunidad beta-1a de canal de sodio con compuerta regulada por voltaje de humano y metodos de usos. | |
TR200200048T2 (tr) | Otoproteolitik klevaj vasıtasıyla proteinlerin üretimi. | |
WO2000071741A3 (en) | Dna encoding a human subunit of the 5-ht3 serotonin receptor | |
DK0774004T3 (da) | DNA-sekvens, som koder for de humane proteiner Tx og Ty, der er beslægtede med Interleukin-1betakonverterende enzym | |
EP1578953A4 (de) | Verfahren zur bestimmung der primärstruktur der für die rekombinante menschliche endooligopeptidase a (heopa) codierenden boten-rna ¬af217798|... | |
GB9708479D0 (en) | Nucleic acids | |
WO2003040343A3 (en) | Polynucleotide and polypeptide sequences of canine cathepsin s |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |